Dyno Therapeutics

Recent Finacing

Series A

Recent Raise

$100M

Dyno Therapeutics' CapsidMap is an AI-driven, high-throughput in vivo platform that designs and evaluates AAV capsids to improve delivery, safety, payload capacity, and immune evasion for liver and CNS

Founded 2018

Massachusetts, United States

101-250

Private

dynotx.com

Highlights

Focus Areas

Artificial Intelligence (AI)

Biotechnology

Health Care

Recent Investors

Financials

$109M

Total Raised

2

Funding rounds

8

Investors

Team

Upgrade to view the team

See the team members at Dyno Therapeutics.